The estimated Net Worth of Elizabeth G Nabel is at least $8.63 Миллион dollars as of 3 September 2024. Elizabeth Nabel owns over 2,179 units of Accolade stock worth over $147,114 and over the last 10 years Elizabeth sold ACCD stock worth over $8,477,964.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Elizabeth Nabel ACCD stock SEC Form 4 insiders trading
Elizabeth has made over 15 trades of the Accolade stock since 2020, according to the Form 4 filled with the SEC. Most recently Elizabeth exercised 2,179 units of ACCD stock worth $8,520 on 3 September 2024.
The largest trade Elizabeth's ever made was selling 73,975 units of Accolade stock on 15 July 2020 worth over $6,497,964. On average, Elizabeth trades about 3,422 units every 38 days since 2015. As of 3 September 2024 Elizabeth still owns at least 37,625 units of Accolade stock.
You can see the complete history of Elizabeth Nabel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Elizabeth Nabel's mailing address?
Elizabeth's mailing address filed with the SEC is C/O ACCOLADE, INC., 1201 THIRD AVENUE, SUITE 1700, SEATTLE, WA, 98101.
Insiders trading at Accolade
Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan и Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.
What does Accolade do?
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
What does Accolade's logo look like?
Complete history of Elizabeth Nabel stock trades at Medtronic Plc, Moderna Inc и Accolade
Accolade executives and stock owners
Accolade executives and other stock owners filed with the SEC include:
-
Rajeev Singh,
Chairman & CEO -
Robert Cavanaugh,
Pres -
Stephen H. Barnes CPA,
CFO & Treasurer -
Michael W. Hilton,
Chief Innovation Officer -
Jennifer Hanson,
Exec. VP of People and Culture & Chief HR Officer -
Britt Provost,
Exec. VP of People & Culture -
Carolina Lobo,
Chief Marketing Officer -
Phong Nguyen,
Chief Operating Officer -
William S. Morrison,
Sr. VP of Strategy & Corp. Devel. -
Richard Eskew,
Exec. VP, Gen. Counsel & Chief Privacy Officer -
Todd Friedman,
Sr. VP of Investor Relations -
Harish Naidu,
Chief Technology Officer -
David Wyatt,
Exec. VP of Operations -
Stephen H. Barnes,
CFO, Treasurer & Sec. -
J. Michael Cline,
Co-Founder & Independent Chairman -
Dawn G Lepore,
Director -
Patricia L Wadors,
Director -
William H. Frist,
Director -
Jeffrey D Jordan,
Director -
Thomas J Neff,
Director -
Capital Partners Ii Co Inve...,
-
James C. Madden,
-
Parallel Fund Iv, L.P.Ah Pa...,
-
Horowitz Fund Iv, L.P.Andre...,
-
J Michael Cline,
Director -
Edgar Jr Bronfman,
-
Rajeev Singh,
Chief Executive Officer -
Stephen H. Barnes,
Chief Financial Officer -
Robert N Cavanaugh,
President -
Cindy Kent,
Director -
Jeffrey S Brodsky,
Director -
Elizabeth G Nabel,
Director -
Peter S Klein,
Director -
Michael W Hilton,
Director -
Richard Eskew,
EVP General Counsel -
Colin Mc Hugh,
Chief Accounting Officer